Skip to Main Content

Paper Details

Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Cancer Chemother Pharmacol
6
2017
Author NameAffiliation
Ho Min KimRinku General Medical Center
  • 1 - 1

Datasets

Release 1.2